We are live on ! Find out more
LABS

Direxion Daily S&P Biotech Bear 1X Shares
LABS

Delisted

LABS was delisted on the 25th of September, 2017.

Back to rankings

2 hedge funds and large institutions have $1.11M invested in Direxion Daily S&P Biotech Bear 1X Shares in 2017 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 2 → 2 (0)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

23% less capital invested

Capital invested by funds: $1.44M → $1.11M (-$335K)

Holders
2
Holders Change
–
Holders Change %
0%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
+$69.4K

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$250K
Name Holding Trade Value Shares
Change 		Change in
Stake
VF
1
Virtu Financial
New York
$863K -$250K -8,029 -21%
Jane Street
2
Jane Street
New York
$246K +$69.4K +2,230 +35%

LABS Hedge Fund Activity: Q2 2017 in Review

2 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bear 1X Shares (LABS) for Q2 2017, worth a combined $1.11M — down 23% from $1.44M a quarter earlier.

Fund positioning in LABS was balanced in Q2 2017: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.

The largest buyer was Jane Street, adding an estimated $69.4K. The largest seller was Virtu Financial, cutting an estimated $250K.

  • 2 institutional investors held Direxion Daily S&P Biotech Bear 1X Shares (LABS) as of Q2 2017, unchanged from Q1 2017.
  • Funds reported $1.11M of Direxion Daily S&P Biotech Bear 1X Shares stock for Q2 2017, down 23% quarter-over-quarter.
  • 0 funds opened new Direxion Daily S&P Biotech Bear 1X Shares positions in Q2 2017 and 0 closed out.
  • The largest Direxion Daily S&P Biotech Bear 1X Shares buyer in Q2 2017 was Jane Street, an estimated $69.4K added.
  • The largest Direxion Daily S&P Biotech Bear 1X Shares seller in Q2 2017 was Virtu Financial, an estimated $250K sold.

Based on aggregated 13F filings for Q2 2017.